Oncotelic Therapeutics (OTLC) Cash from Operations (2010 - 2026)
Oncotelic Therapeutics (OTLC) recorded Cash from Operations of -$799,872 in Q4 2025, compared with -$103,890 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Cash from Operations (2010 - 2026) Analysis & Trends
For FY2025, Oncotelic Therapeutics reported Cash from Operations of -$1.4 million.
- Across earlier years, Cash from Operations came in at -$740,277 in FY2024, -$1.32 million in FY2023, -$1.45 million in FY2022 and -$4.43 million in FY2021.
- The Q4 2025 figure is the lowest quarterly Cash from Operations since Q1 2022.
- Per Business Quant, the preceding three quarters came in at -$307,022 (Q3 2025), -$93,106 (Q2 2025) and -$200,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 11.40 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 7.61 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 6.56 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.67 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 4.24 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 5.04 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 5.38 Bn |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | -92,197.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -92,197.00 |
| Mar 31, 2026 | -342,243.00 |
| Dec 31, 2025 | -799,872.00 |
| Sep 30, 2025 | -307,022.00 |
| Jun 30, 2025 | -93,106.00 |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | -103,890.00 |
| Sep 30, 2024 | -143,198.00 |
| Jun 30, 2024 | -261,773.00 |
| Mar 31, 2024 | -231,416.00 |
| Dec 31, 2023 | -372,617.00 |
| Sep 30, 2023 | -248,850.00 |
| Jun 30, 2023 | -448,563.00 |
| Mar 31, 2023 | -251,017.00 |
| Dec 31, 2022 | -80,680.00 |
| Sep 30, 2022 | -206,083.00 |
| Jun 30, 2022 | -203,131.00 |
| Mar 31, 2022 | -962,668.00 |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -900,685.00 |
API Access
Oncotelic Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();